miR-1 Exacerbates Cardiac Ischemia-Reperfusion Injury in Mouse Models

Zhenwei Pan; Xuelin Sun; Jinshuai Ren; Xin Li; Xu Gao; Chunying Lu; Yang Zhang; Hui Sun; Ying Wang; Huimin Wang; Jinghao Wang; Liangjun Xie; Yanjie Lu; Baofeng Yang

doi:10.1371/journal.pone.0050515

Loading metrics

Open Access

Peer-reviewed

Research Article

miR-1 Exacerbates Cardiac Ischemia-Reperfusion Injury in Mouse Models

Zhenwei Pan ,

Contributed equally to this work with: Zhenwei Pan, Xuelin Sun

* E-mail: yjlu86@yahoo.com (YL); panzw@ems.hrbmu.edu.cn (ZP)

Affiliation Department of Pharmacology (Key Laboratory of Cardiovascular Medicine Research, Ministry of Education; State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, Harbin, Heilongjiang, People’s Republic of China
⨯
Xuelin Sun ,

Contributed equally to this work with: Zhenwei Pan, Xuelin Sun

Affiliation Department of Pharmacology (Key Laboratory of Cardiovascular Medicine Research, Ministry of Education; State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, Harbin, Heilongjiang, People’s Republic of China
⨯
Jinshuai Ren,

Affiliation Department of Pharmacology (Key Laboratory of Cardiovascular Medicine Research, Ministry of Education; State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, Harbin, Heilongjiang, People’s Republic of China
⨯
Xin Li,

Affiliation Department of Pharmacology (Key Laboratory of Cardiovascular Medicine Research, Ministry of Education; State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, Harbin, Heilongjiang, People’s Republic of China
⨯
Xu Gao,

Affiliation Departments of Biochemistry, Harbin Medical University, Harbin, Heilongjiang, People’s Republic of China
⨯
Chunying Lu,

Affiliation Department of Pharmacology (Key Laboratory of Cardiovascular Medicine Research, Ministry of Education; State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, Harbin, Heilongjiang, People’s Republic of China
⨯
Yang Zhang,

Affiliation Department of Pharmacology (Key Laboratory of Cardiovascular Medicine Research, Ministry of Education; State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, Harbin, Heilongjiang, People’s Republic of China
⨯
Hui Sun,

Affiliation Department of Pharmacology (Key Laboratory of Cardiovascular Medicine Research, Ministry of Education; State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, Harbin, Heilongjiang, People’s Republic of China
⨯
Ying Wang,

Affiliation Department of Pharmacology (Key Laboratory of Cardiovascular Medicine Research, Ministry of Education; State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, Harbin, Heilongjiang, People’s Republic of China
⨯
Huimin Wang,

Affiliation Department of Pharmacology (Key Laboratory of Cardiovascular Medicine Research, Ministry of Education; State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, Harbin, Heilongjiang, People’s Republic of China
⨯
Jinghao Wang,

Affiliation Department of Pharmacology (Key Laboratory of Cardiovascular Medicine Research, Ministry of Education; State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, Harbin, Heilongjiang, People’s Republic of China
⨯
Liangjun Xie,

Affiliation Department of Pharmacology (Key Laboratory of Cardiovascular Medicine Research, Ministry of Education; State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, Harbin, Heilongjiang, People’s Republic of China
⨯
Yanjie Lu ,

* E-mail: yjlu86@yahoo.com (YL); panzw@ems.hrbmu.edu.cn (ZP)

Affiliation Department of Pharmacology (Key Laboratory of Cardiovascular Medicine Research, Ministry of Education; State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, Harbin, Heilongjiang, People’s Republic of China
⨯
Baofeng Yang

Affiliation Department of Pharmacology (Key Laboratory of Cardiovascular Medicine Research, Ministry of Education; State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, Harbin, Heilongjiang, People’s Republic of China
⨯

miR-1 Exacerbates Cardiac Ischemia-Reperfusion Injury in Mouse Models

Zhenwei Pan,
Xuelin Sun,
Jinshuai Ren,
Xin Li,
Xu Gao,
Chunying Lu,
Yang Zhang,
Hui Sun,
Ying Wang,
Huimin Wang

Published: November 30, 2012
https://doi.org/10.1371/journal.pone.0050515

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Genetically modified animals
Is the Subject Area "Genetically modified animals" applicable to this article?

Thanks for your feedback.
MicroRNAs
Is the Subject Area "MicroRNAs" applicable to this article?

Thanks for your feedback.
Heart
Is the Subject Area "Heart" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Heat shock response
Is the Subject Area "Heat shock response" applicable to this article?

Thanks for your feedback.
Luciferase
Is the Subject Area "Luciferase" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Hyperexpression techniques
Is the Subject Area "Hyperexpression techniques" applicable to this article?

Thanks for your feedback.